Evogene Ltd. EVGN

0.42 0.00 0.00% as of 25 Sep
Market cap
$6.3M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
19.76 26.35 29.19 51.99 127.26 71.30 17.96 7.08 1.91 2.25
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(30.54) (24.98) 12.77 (8.40) (19.26) (8.20) (13.33) (6.74) (2.34) (3.22)
P/B ratio
1.48 1.28 1.01 0.65 2.33 1.05 0.86 1.39 0.72 0.72
Price to Tangible BV
1.48 1.28 1.01 0.91 3.25 1.38 1.46 2.57 4.03 433.07
EV/Sales
6.28 5.13 (1.99) (10.27) 80.88 13.38 (3.15) 1.57 (0.84) (1.12)
EV/EBITDA
0.00 0.00 0.18 0.42 0.00 0.00 0.22 0.00 0.27 0.37
EV/Operating CF
(3.52) (1.09) 0.42 0.44 (4.31) (0.50) 0.22 (0.41) 0.24 0.32
EV/FCF
(3.29) (1.05) 0.42 0.42 (4.17) (0.49) 0.21 (0.40) 0.23 0.32
Quick Ratio
17.13 15.61 10.22 8.53 5.36 8.25 6.61 4.95 0.99 4.32
Current Ratio
17.13 15.61 10.22 8.53 5.36 8.27 6.71 4.96 1.15 4.54
Net Debt/EBITDA
4.69 3.62 3.03 2.55 2.18 1.88 1.45 1.30 0.90 1.12
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.06 0.04 0.03 0.01 0.01 0.01 0.03 0.11 0.12 0.13
Operating CF/Net income
0.60 0.76 0.73 0.98 0.83 0.89 0.89 0.90 1.20 1.59
Capex/Depreciation
(0.35) (0.28) (0.19) (0.32) (0.25) (0.38) (0.45) (0.29) (0.33) (0.02)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(20.51%) (26.60%) (34.69%) (32.78%) (39.92%) (46.21%) (54.25%) (75.24%) (75.75%) (63.29%)
ROA
(18.79%) (24.01%) (30.46%) (27.85%) (32.63%) (37.50%) (40.23%) (44.54%) (36.24%) (28.33%)
ROIC
0.00% 0.00% 0.00% (99.16%) (179.23%) (202.49%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(21.59%) (28.58%) (38.99%) (39.49%) (52.86%) (53.36%) (76.93%) (79.65%) (350.89%) (65.27%)
Average Days of Receivables
74.34 111.84 213.32 1,042.65 1,261.36 1,150.73 398.78 215.51 206.49 178.28
Research and Development Expense of Revenue
250.84% 502.43% 840.64% 2,097.08% 1,662.21% 2,271.51% 1,241.31% 368.39% 224.33% 207.47%
Selling, General and Administrative Expense of Revenue
59.46% 112.69% 201.14% 500.00% 511.63% 1,074.30% 621.79% 171.61% 160.95% 149.55%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.24 0.22 0.20 0.25 0.26 0.31 0.00
Share Based Compensation of Revenue
45.00% 66.37% 99.08% 209.56% 393.94% 280.54% 70.81% 33.28% 22.29% 16.97%
Graham Net Nets
0.63 0.72 0.92 0.97 0.28 0.66 0.55 0.30 (0.32) 0.87
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(15.16%) (23.34%) (41.41%) (46.71%) (17.45%) (42.07%) (87.67%) (60.92%) (166.31%) (106.36%)
Free Cash Flow Yield
(9.67%) (18.54%) (16.42%) (47.43%) (15.26%) (38.55%) (82.60%) (55.95%) (190.70%) (156.55%)
Revenue per Share
2.57 1.32 0.68 0.29 0.37 0.23 0.41 1.23 0.98 0.49
Operating CF per Share
(4.60) (6.20) (5.89) (6.86) (6.93) (6.11) (5.75) (4.70) (3.46) (1.71)
Capex per Share
(0.32) (0.23) (0.15) (0.35) (0.24) (0.21) (0.28) (0.17) (0.11) (0.01)
Free Cash Flow per Share
(4.91) (6.43) (6.03) (7.21) (7.17) (6.32) (6.03) (4.87) (3.57) (1.72)
Cash per Share
34.65 27.95 21.15 18.20 17.13 13.32 8.58 6.77 2.69 1.65
Shareholders Equity per Share
34.31 27.02 19.53 23.38 20.20 15.69 8.44 6.25 2.60 1.52
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
34.31 27.02 19.53 23.38 20.20 15.69 8.44 6.25 2.60 1.52
Free Cash Flow
(12.50) (16.52) (15.53) (18.57) (20.20) (25.56) (24.85) (22.34) (20.32) (13.56)
Working Capital
84.27 68.13 50.06 43.28 42.15 50.01 32.13 27.53 2.89 12.19
Capital Expenditures
(0.80) (0.59) (0.37) (0.90) (0.68) (0.85) (1.17) (0.76) (0.62) (0.06)
Net Current Asset Value
80.79 64.57 47.10 37.88 36.79 44.01 16.42 12.05 (3.44) 7.56
EV/EBIT
0.00 0.00 0.17 0.37 0.00 0.00 0.20 0.00 0.25 0.31
Capex to Sales
0.12 0.17 0.21 1.20 0.66 0.91 0.70 0.13 0.11 0.01
Net Profit Margin
(299.57%) (616.33%) (1,188.21%) (2,405.31%) (2,247.50%) (2,988.49%) (1,590.33%) (423.39%) (295.59%) (220.22%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.35 0.45 0.63 1.07 1.32 1.08 1.03 1.06 1.03 3.04
Cash ROIC
(10.36%) (14.68%) (17.51%) (18.91%) (20.54%) (22.84%) (37.32%) (40.22%) (71.33%) (57.34%)
Accounts Receivable Turnover
2.60 2.86 1.70 0.47 0.36 0.29 0.70 2.19 1.72 1.53
Accounts Payable Turnover
3.64 2.33 1.37 0.33 0.62 0.66 0.73 1.20 1.58 4.39
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 2.76 5.27 2.51 4.04
Average Days of Payables
86.09 142.41 255.15 1,093.91 548.77 696.21 416.00 385.06 188.33 56.97
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 43.78 227.27 16.39 278.96 18.72
Average Receivables
2.52 1.18 1.03 1.59 2.87 3.26 2.38 2.58 3.24 2.52
Average Payables
1.55 1.22 1.06 1.01 0.93 1.16 1.25 1.41 1.51 0.93
Average Inventory
— — — — — — 0.33 0.32 0.95 1.01
Average Assets
104.29 86.79 68.15 65.03 71.64 74.11 66.22 53.61 45.48 29.96
Average Common Equity
95.52 78.33 59.84 55.26 58.55 60.15 49.11 31.74 21.76 13.41

Fold the line items

Columns are period end dates